APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Solid Dosage Form Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Solid Dosage Form Drug Industry Growth and Trends Forecast to 2032

Report ID 174036750120 December 2025110 pages

Choose your research edition.

Industry ResearchSolid Dosage Form Drug Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Solid Dosage Form Drug Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Solid Dosage Form Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Solid Dosage Form Drug Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Solid Dosage Form Drug Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

According to APO Research, the global Solid Dosage Form Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Solid Dosage Form Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Solid Dosage Form Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Solid Dosage Form Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Solid Dosage Form Drug market include Takeda, Teva, Sanofi, Johnson & Johnson, Novartis, Roche, Eli Lilly & Co., Pfizer and GlaxoSmithKline, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Solid Dosage Form Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Solid Dosage Form Drug market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Solid Dosage Form Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Solid Dosage Form Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Solid Dosage Form Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Solid Dosage Form Drug Market by Company

Takeda

Teva

Sanofi

Johnson & Johnson

Novartis

Roche

Eli Lilly & Co.

Pfizer

GlaxoSmithKline

Biogen

Bayer

Bristol Myers Squibb

Amgen

AbbVie

AstraZeneca

Merck & Co.

Gilead Sciences

Boehringer Ingelheim

Astellas

Solid Dosage Form Drug Segment by Type

Tablet

Capsules

Other

Solid Dosage Form Drug Segment by Application

Hospital

Retail Pharmacy

Other

Solid Dosage Form Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Solid Dosage Form Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Solid Dosage Form Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Solid Dosage Form Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Solid Dosage Form Drug companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Solid Dosage Form Drug Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Solid Dosage Form Drug Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Solid Dosage Form Drug Market Share by Region (2021-2026) Table 4. Global Solid Dosage Form Drug Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Solid Dosage Form Drug Market Share by Region (2027-2032) Table 6. Global Solid Dosage Form Drug Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Solid Dosage Form Drug Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Solid Dosage Form Drug Market Size Share by Type (2021-2026) Table 9. Global Solid Dosage Form Drug Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Solid Dosage Form Drug Market Size Share Forecasted by Type (2027-2032) Table 11. North America Solid Dosage Form Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Solid Dosage Form Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Solid Dosage Form Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Solid Dosage Form Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Solid Dosage Form Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Solid Dosage Form Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Solid Dosage Form Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Solid Dosage Form Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Solid Dosage Form Drug Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Solid Dosage Form Drug Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Solid Dosage Form Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Solid Dosage Form Drug Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Solid Dosage Form Drug Market Size Share by Application (2021-2026) Table 24. Global Solid Dosage Form Drug Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Solid Dosage Form Drug Market Size Share Forecasted by Application (2027-2032) Table 26. North America Solid Dosage Form Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Solid Dosage Form Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Solid Dosage Form Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Solid Dosage Form Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Solid Dosage Form Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Solid Dosage Form Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Solid Dosage Form Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Solid Dosage Form Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Solid Dosage Form Drug Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Solid Dosage Form Drug Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Solid Dosage Form Drug Industry Trends Table 37. Solid Dosage Form Drug Industry Drivers Table 38. Solid Dosage Form Drug Industry Opportunities and Challenges Table 39. Solid Dosage Form Drug Industry Restraints Table 40. Global Solid Dosage Form Drug Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Solid Dosage Form Drug Revenue Market Share by Company (2021-2026) Table 42. Global Solid Dosage Form Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Solid Dosage Form Drug Key Company Headquarters & Area Served Table 44. Global Solid Dosage Form Drug Company, Product Type & Application Table 45. Global Solid Dosage Form Drug Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Solid Dosage Form Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Takeda Company Information Table 49. Takeda Business Overview Table 50. Takeda Solid Dosage Form Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Takeda Solid Dosage Form Drug Product Portfolio Table 52. Takeda Recent Development Table 53. Teva Company Information Table 54. Teva Business Overview Table 55. Teva Solid Dosage Form Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Teva Solid Dosage Form Drug Product Portfolio Table 57. Teva Recent Development Table 58. Sanofi Company Information Table 59. Sanofi Business Overview Table 60. Sanofi Solid Dosage Form Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Sanofi Solid Dosage Form Drug Product Portfolio Table 62. Sanofi Recent Development Table 63. Johnson & Johnson Company Information Table 64. Johnson & Johnson Business Overview Table 65. Johnson & Johnson Solid Dosage Form Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Johnson & Johnson Solid Dosage Form Drug Product Portfolio Table 67. Johnson & Johnson Recent Development Table 68. Novartis Company Information Table 69. Novartis Business Overview Table 70. Novartis Solid Dosage Form Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Novartis Solid Dosage Form Drug Product Portfolio Table 72. Novartis Recent Development Table 73. Roche Company Information Table 74. Roche Business Overview Table 75. Roche Solid Dosage Form Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Roche Solid Dosage Form Drug Product Portfolio Table 77. Roche Recent Development Table 78. Eli Lilly & Co. Company Information Table 79. Eli Lilly & Co. Business Overview Table 80. Eli Lilly & Co. Solid Dosage Form Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Eli Lilly & Co. Solid Dosage Form Drug Product Portfolio Table 82. Eli Lilly & Co. Recent Development Table 83. Pfizer Company Information Table 84. Pfizer Business Overview Table 85. Pfizer Solid Dosage Form Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Pfizer Solid Dosage Form Drug Product Portfolio Table 87. Pfizer Recent Development Table 88. GlaxoSmithKline Company Information Table 89. GlaxoSmithKline Business Overview Table 90. GlaxoSmithKline Solid Dosage Form Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. GlaxoSmithKline Solid Dosage Form Drug Product Portfolio Table 92. GlaxoSmithKline Recent Development Table 93. Biogen Company Information Table 94. Biogen Business Overview Table 95. Biogen Solid Dosage Form Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Biogen Solid Dosage Form Drug Product Portfolio Table 97. Biogen Recent Development Table 98. Bayer Company Information Table 99. Bayer Business Overview Table 100. Bayer Solid Dosage Form Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Bayer Solid Dosage Form Drug Product Portfolio Table 102. Bayer Recent Development Table 103. Bristol Myers Squibb Company Information Table 104. Bristol Myers Squibb Business Overview Table 105. Bristol Myers Squibb Solid Dosage Form Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Bristol Myers Squibb Solid Dosage Form Drug Product Portfolio Table 107. Bristol Myers Squibb Recent Development Table 108. Amgen Company Information Table 109. Amgen Business Overview Table 110. Amgen Solid Dosage Form Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Amgen Solid Dosage Form Drug Product Portfolio Table 112. Amgen Recent Development Table 113. AbbVie Company Information Table 114. AbbVie Business Overview Table 115. AbbVie Solid Dosage Form Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. AbbVie Solid Dosage Form Drug Product Portfolio Table 117. AbbVie Recent Development Table 118. AstraZeneca Company Information Table 119. AstraZeneca Business Overview Table 120. AstraZeneca Solid Dosage Form Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. AstraZeneca Solid Dosage Form Drug Product Portfolio Table 122. AstraZeneca Recent Development Table 123. Merck & Co. Company Information Table 124. Merck & Co. Business Overview Table 125. Merck & Co. Solid Dosage Form Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Merck & Co. Solid Dosage Form Drug Product Portfolio Table 127. Merck & Co. Recent Development Table 128. Gilead Sciences Company Information Table 129. Gilead Sciences Business Overview Table 130. Gilead Sciences Solid Dosage Form Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Gilead Sciences Solid Dosage Form Drug Product Portfolio Table 132. Gilead Sciences Recent Development Table 133. Boehringer Ingelheim Company Information Table 134. Boehringer Ingelheim Business Overview Table 135. Boehringer Ingelheim Solid Dosage Form Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Boehringer Ingelheim Solid Dosage Form Drug Product Portfolio Table 137. Boehringer Ingelheim Recent Development Table 138. Astellas Company Information Table 139. Astellas Business Overview Table 140. Astellas Solid Dosage Form Drug Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Astellas Solid Dosage Form Drug Product Portfolio Table 142. Astellas Recent Development Table 143. North America Solid Dosage Form Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. North America Solid Dosage Form Drug Market Size by Country (2021-2026) & (US$ Million) Table 145. North America Solid Dosage Form Drug Market Share by Country (2021-2026) Table 146. North America Solid Dosage Form Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. North America Solid Dosage Form Drug Market Share Forecast by Country (2027-2032) Table 148. Europe Solid Dosage Form Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Europe Solid Dosage Form Drug Market Size by Country (2021-2026) & (US$ Million) Table 150. Europe Solid Dosage Form Drug Market Share by Country (2021-2026) Table 151. Europe Solid Dosage Form Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Europe Solid Dosage Form Drug Market Share Forecast by Country (2027-2032) Table 153. Asia-Pacific Solid Dosage Form Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Asia-Pacific Solid Dosage Form Drug Market Size by Country (2021-2026) & (US$ Million) Table 155. Asia-Pacific Solid Dosage Form Drug Market Share by Country (2021-2026) Table 156. Asia-Pacific Solid Dosage Form Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Asia-Pacific Solid Dosage Form Drug Market Share Forecast by Country (2027-2032) Table 158. Latin America Solid Dosage Form Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Latin America Solid Dosage Form Drug Market Size by Country (2021-2026) & (US$ Million) Table 160. Latin America Solid Dosage Form Drug Market Share by Country (2021-2026) Table 161. Latin America Solid Dosage Form Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Latin America Solid Dosage Form Drug Market Share Forecast by Country (2027-2032) Table 163. Middle East & Africa Solid Dosage Form Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Middle East & Africa Solid Dosage Form Drug Market Size by Country (2021-2026) & (US$ Million) Table 165. Middle East & Africa Solid Dosage Form Drug Market Share by Country (2021-2026) Table 166. Middle East & Africa Solid Dosage Form Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Middle East & Africa Solid Dosage Form Drug Market Share Forecast by Country (2027-2032) Table 168. Research Programs/Design for This Report Table 169. Authors List of This Report Table 170. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Solid Dosage Form Drug Product Image Figure 3. Global Solid Dosage Form Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Solid Dosage Form Drug Market Size (2021-2032) & (US$ Million) Figure 5. Global Solid Dosage Form Drug Market Share by Region: 2025 VS 2032 Figure 6. Global Solid Dosage Form Drug Market Share by Region (2021-2032) Figure 7. North America Solid Dosage Form Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Solid Dosage Form Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Solid Dosage Form Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Solid Dosage Form Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Solid Dosage Form Drug Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Tablet Image Figure 13. Global Tablet Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Capsules Image Figure 15. Global Capsules Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Other Image Figure 17. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Solid Dosage Form Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Solid Dosage Form Drug Market Share by Type 2025 VS 2032 Figure 20. North America Solid Dosage Form Drug Market Size Share by Type (2021-2032) Figure 21. Europe Solid Dosage Form Drug Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Solid Dosage Form Drug Market Size Share by Type (2021-2032) Figure 23. Latin America Solid Dosage Form Drug Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Solid Dosage Form Drug Market Size Share by Type (2021-2032) Figure 25. Hospital Image Figure 26. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Retail Pharmacy Image Figure 28. Global Retail Pharmacy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Other Image Figure 30. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Global Solid Dosage Form Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Solid Dosage Form Drug Market Share by Application 2025 VS 2032 Figure 33. North America Solid Dosage Form Drug Market Size Share by Application (2021-2032) Figure 34. Europe Solid Dosage Form Drug Market Size Share by Application (2021-2032) Figure 35. Asia-Pacific Solid Dosage Form Drug Market Size Share by Application (2021-2032) Figure 36. Latin America Solid Dosage Form Drug Market Size Share by Application (2021-2032) Figure 37. Middle East and Africa Solid Dosage Form Drug Market Size Share by Application (2021-2032) Figure 38. Global Top 5 and 10 Solid Dosage Form Drug Players Market Share by Revenue in 2025 Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 40. North America Solid Dosage Form Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. North America Solid Dosage Form Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. North America Solid Dosage Form Drug Market Share by Country (2021-2032) Figure 43. Europe Solid Dosage Form Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Europe Solid Dosage Form Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Solid Dosage Form Drug Market Share by Country (2021-2032) Figure 46. Asia-Pacific Solid Dosage Form Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Asia-Pacific Solid Dosage Form Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Asia-Pacific Solid Dosage Form Drug Market Share by Country (2021-2032) Figure 49. Latin America Solid Dosage Form Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Latin America Solid Dosage Form Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Solid Dosage Form Drug Market Share by Country (2021-2032) Figure 52. Middle East & Africa Solid Dosage Form Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Middle East & Africa Solid Dosage Form Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Middle East & Africa Solid Dosage Form Drug Market Share by Country (2021-2032) Figure 55. Years Considered Figure 56. Research Process Figure 57. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Capsules
  • Other
Applications
  • Hospital
  • Retail Pharmacy
  • Other
Companies covered
  • Takeda
  • Teva
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Roche
  • Eli Lilly & Co.
  • Pfizer
  • GlaxoSmithKline
  • Biogen
  • Bayer
  • Bristol Myers Squibb
  • Amgen
  • AbbVie
  • AstraZeneca
  • Merck & Co.
  • Gilead Sciences
  • Boehringer Ingelheim
  • Astellas

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Solid Dosage Form Drug Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Solid Dosage Form Drug Market Size by Region (2021-2032)
  5. 1.4.1 Global Solid Dosage Form Drug Market Size by Region (2021-2026)
  6. 1.4.2 Global Solid Dosage Form Drug Market Size by Region (2027-2032)
  7. 1.5 Key Regions Solid Dosage Form Drug Market Size (2021-2032)
  8. 1.5.1 North America Solid Dosage Form Drug Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Solid Dosage Form Drug Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Solid Dosage Form Drug Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Solid Dosage Form Drug Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Solid Dosage Form Drug Market Size Growth Rate (2021-2032)
2 Solid Dosage Form Drug Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Tablet
  3. 2.1.2 Capsules
  4. 2.1.3 Other
  5. 2.2 Global Solid Dosage Form Drug Market Size by Type
  6. 2.2.1 Global Solid Dosage Form Drug Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Solid Dosage Form Drug Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Solid Dosage Form Drug Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Solid Dosage Form Drug Market Size by Regions
  10. 2.3.1 North America Solid Dosage Form Drug Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Solid Dosage Form Drug Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Solid Dosage Form Drug Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Solid Dosage Form Drug Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Solid Dosage Form Drug Market Size Breakdown by Type (2021-2026)
3 Solid Dosage Form Drug Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital
  3. 3.1.2 Retail Pharmacy
  4. 3.1.3 Other
  5. 3.2 Global Solid Dosage Form Drug Market Size by Application
  6. 3.2.1 Global Solid Dosage Form Drug Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Solid Dosage Form Drug Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Solid Dosage Form Drug Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Solid Dosage Form Drug Market Size by Regions
  10. 3.3.1 North America Solid Dosage Form Drug Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Solid Dosage Form Drug Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Solid Dosage Form Drug Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Solid Dosage Form Drug Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Solid Dosage Form Drug Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Solid Dosage Form Drug Industry Trends
  2. 4.2 Solid Dosage Form Drug Industry Drivers
  3. 4.3 Solid Dosage Form Drug Industry Opportunities and Challenges
  4. 4.4 Solid Dosage Form Drug Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Solid Dosage Form Drug Revenue (2021-2026)
  2. 5.2 Global Solid Dosage Form Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Solid Dosage Form Drug Key Company Headquarters & Area Served
  4. 5.4 Global Solid Dosage Form Drug Company, Product Type & Application
  5. 5.5 Global Solid Dosage Form Drug Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Solid Dosage Form Drug Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Solid Dosage Form Drug Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Solid Dosage Form Drug Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda Solid Dosage Form Drug Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Solid Dosage Form Drug Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 Teva
  8. 6.2.1 Teva Company Information
  9. 6.2.2 Teva Business Overview
  10. 6.2.3 Teva Solid Dosage Form Drug Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Teva Solid Dosage Form Drug Product Portfolio
  12. 6.2.5 Teva Recent Developments
  13. 6.3 Sanofi
  14. 6.3.1 Sanofi Company Information
  15. 6.3.2 Sanofi Business Overview
  16. 6.3.3 Sanofi Solid Dosage Form Drug Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Sanofi Solid Dosage Form Drug Product Portfolio
  18. 6.3.5 Sanofi Recent Developments
  19. 6.4 Johnson & Johnson
  20. 6.4.1 Johnson & Johnson Company Information
  21. 6.4.2 Johnson & Johnson Business Overview
  22. 6.4.3 Johnson & Johnson Solid Dosage Form Drug Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Johnson & Johnson Solid Dosage Form Drug Product Portfolio
  24. 6.4.5 Johnson & Johnson Recent Developments
  25. 6.5 Novartis
  26. 6.5.1 Novartis Company Information
  27. 6.5.2 Novartis Business Overview
  28. 6.5.3 Novartis Solid Dosage Form Drug Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Novartis Solid Dosage Form Drug Product Portfolio
  30. 6.5.5 Novartis Recent Developments
  31. 6.6 Roche
  32. 6.6.1 Roche Company Information
  33. 6.6.2 Roche Business Overview
  34. 6.6.3 Roche Solid Dosage Form Drug Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Roche Solid Dosage Form Drug Product Portfolio
  36. 6.6.5 Roche Recent Developments
  37. 6.7 Eli Lilly & Co.
  38. 6.7.1 Eli Lilly & Co. Company Information
  39. 6.7.2 Eli Lilly & Co. Business Overview
  40. 6.7.3 Eli Lilly & Co. Solid Dosage Form Drug Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Eli Lilly & Co. Solid Dosage Form Drug Product Portfolio
  42. 6.7.5 Eli Lilly & Co. Recent Developments
  43. 6.8 Pfizer
  44. 6.8.1 Pfizer Company Information
  45. 6.8.2 Pfizer Business Overview
  46. 6.8.3 Pfizer Solid Dosage Form Drug Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Pfizer Solid Dosage Form Drug Product Portfolio
  48. 6.8.5 Pfizer Recent Developments
  49. 6.9 GlaxoSmithKline
  50. 6.9.1 GlaxoSmithKline Company Information
  51. 6.9.2 GlaxoSmithKline Business Overview
  52. 6.9.3 GlaxoSmithKline Solid Dosage Form Drug Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 GlaxoSmithKline Solid Dosage Form Drug Product Portfolio
  54. 6.9.5 GlaxoSmithKline Recent Developments
  55. 6.10 Biogen
  56. 6.10.1 Biogen Company Information
  57. 6.10.2 Biogen Business Overview
  58. 6.10.3 Biogen Solid Dosage Form Drug Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Biogen Solid Dosage Form Drug Product Portfolio
  60. 6.10.5 Biogen Recent Developments
  61. 6.11 Bayer
  62. 6.11.1 Bayer Company Information
  63. 6.11.2 Bayer Business Overview
  64. 6.11.3 Bayer Solid Dosage Form Drug Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Bayer Solid Dosage Form Drug Product Portfolio
  66. 6.11.5 Bayer Recent Developments
  67. 6.12 Bristol Myers Squibb
  68. 6.12.1 Bristol Myers Squibb Company Information
  69. 6.12.2 Bristol Myers Squibb Business Overview
  70. 6.12.3 Bristol Myers Squibb Solid Dosage Form Drug Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Bristol Myers Squibb Solid Dosage Form Drug Product Portfolio
  72. 6.12.5 Bristol Myers Squibb Recent Developments
  73. 6.13 Amgen
  74. 6.13.1 Amgen Company Information
  75. 6.13.2 Amgen Business Overview
  76. 6.13.3 Amgen Solid Dosage Form Drug Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Amgen Solid Dosage Form Drug Product Portfolio
  78. 6.13.5 Amgen Recent Developments
  79. 6.14 AbbVie
  80. 6.14.1 AbbVie Company Information
  81. 6.14.2 AbbVie Business Overview
  82. 6.14.3 AbbVie Solid Dosage Form Drug Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 AbbVie Solid Dosage Form Drug Product Portfolio
  84. 6.14.5 AbbVie Recent Developments
  85. 6.15 AstraZeneca
  86. 6.15.1 AstraZeneca Company Information
  87. 6.15.2 AstraZeneca Business Overview
  88. 6.15.3 AstraZeneca Solid Dosage Form Drug Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 AstraZeneca Solid Dosage Form Drug Product Portfolio
  90. 6.15.5 AstraZeneca Recent Developments
  91. 6.16 Merck & Co.
  92. 6.16.1 Merck & Co. Company Information
  93. 6.16.2 Merck & Co. Business Overview
  94. 6.16.3 Merck & Co. Solid Dosage Form Drug Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Merck & Co. Solid Dosage Form Drug Product Portfolio
  96. 6.16.5 Merck & Co. Recent Developments
  97. 6.17 Gilead Sciences
  98. 6.17.1 Gilead Sciences Company Information
  99. 6.17.2 Gilead Sciences Business Overview
  100. 6.17.3 Gilead Sciences Solid Dosage Form Drug Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Gilead Sciences Solid Dosage Form Drug Product Portfolio
  102. 6.17.5 Gilead Sciences Recent Developments
  103. 6.18 Boehringer Ingelheim
  104. 6.18.1 Boehringer Ingelheim Company Information
  105. 6.18.2 Boehringer Ingelheim Business Overview
  106. 6.18.3 Boehringer Ingelheim Solid Dosage Form Drug Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Boehringer Ingelheim Solid Dosage Form Drug Product Portfolio
  108. 6.18.5 Boehringer Ingelheim Recent Developments
  109. 6.19 Astellas
  110. 6.19.1 Astellas Company Information
  111. 6.19.2 Astellas Business Overview
  112. 6.19.3 Astellas Solid Dosage Form Drug Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Astellas Solid Dosage Form Drug Product Portfolio
  114. 6.19.5 Astellas Recent Developments
7 North America
  1. 7.1 North America Solid Dosage Form Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Solid Dosage Form Drug Market Size by Country (2021-2026)
  3. 7.3 North America Solid Dosage Form Drug Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Solid Dosage Form Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Solid Dosage Form Drug Market Size by Country (2021-2026)
  3. 8.3 Europe Solid Dosage Form Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Solid Dosage Form Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Solid Dosage Form Drug Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Solid Dosage Form Drug Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Solid Dosage Form Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Solid Dosage Form Drug Market Size by Country (2021-2026)
  3. 10.3 South America Solid Dosage Form Drug Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Solid Dosage Form Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Solid Dosage Form Drug Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Solid Dosage Form Drug Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst